These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 24441508)
1. Beyond radio-displacement techniques for identification of CB1 ligands: the first application of a fluorescence-quenching assay. Bruno A; Lembo F; Novellino E; Stornaiuolo M; Marinelli L Sci Rep; 2014 Jan; 4():3757. PubMed ID: 24441508 [TBL] [Abstract][Full Text] [Related]
2. Endogenous vs Exogenous Allosteric Modulators in GPCRs: A dispute for shuttling CB1 among different membrane microenvironments. Stornaiuolo M; Bruno A; Botta L; La Regina G; Cosconati S; Silvestri R; Marinelli L; Novellino E Sci Rep; 2015 Oct; 5():15453. PubMed ID: 26482099 [TBL] [Abstract][Full Text] [Related]
3. Allosteric modulator ORG27569 induces CB1 cannabinoid receptor high affinity agonist binding state, receptor internalization, and Gi protein-independent ERK1/2 kinase activation. Ahn KH; Mahmoud MM; Kendall DA J Biol Chem; 2012 Apr; 287(15):12070-82. PubMed ID: 22343625 [TBL] [Abstract][Full Text] [Related]
5. In silico mapping of allosteric ligand binding sites in type-1 cannabinoid receptor. Sabatucci A; Tortolani D; Dainese E; Maccarrone M Biotechnol Appl Biochem; 2018 Jan; 65(1):21-28. PubMed ID: 28833445 [TBL] [Abstract][Full Text] [Related]
6. A kinetic model for positive allosteric modulator (PAM)-antagonists for the type 1 cannabinoid (CB Yang L; Zhu X; Finlay DB; Green H; Glass M; Duffull SB Br J Pharmacol; 2023 Oct; 180(20):2661-2676. PubMed ID: 37277184 [TBL] [Abstract][Full Text] [Related]
7. Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors. Tham M; Yilmaz O; Alaverdashvili M; Kelly MEM; Denovan-Wright EM; Laprairie RB Br J Pharmacol; 2019 May; 176(10):1455-1469. PubMed ID: 29981240 [TBL] [Abstract][Full Text] [Related]
8. Structural dynamics and energetics underlying allosteric inactivation of the cannabinoid receptor CB1. Fay JF; Farrens DL Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8469-74. PubMed ID: 26100912 [TBL] [Abstract][Full Text] [Related]
9. Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target. Janero DR; Thakur GA Expert Opin Drug Discov; 2016 Dec; 11(12):1223-1237. PubMed ID: 27712124 [TBL] [Abstract][Full Text] [Related]
10. Parameterization of Org27569: an allosteric modulator of the cannabinoid CB1 G protein-coupled receptor. Iliff HA; Lynch DL; Kotsikorou E; Reggio PH J Comput Chem; 2011 Jul; 32(10):2119-26. PubMed ID: 21523790 [TBL] [Abstract][Full Text] [Related]
11. Allosteric modulators of cannabinoid receptor 1: developing compounds for improved specificity. Dopart R; Lu D; Lichtman AH; Kendall DA Drug Metab Rev; 2018 Feb; 50(1):3-13. PubMed ID: 29355030 [TBL] [Abstract][Full Text] [Related]
13. The membrane proximal region of the cannabinoid receptor CB1 N-terminus can allosterically modulate ligand affinity. Fay JF; Farrens DL Biochemistry; 2013 Nov; 52(46):8286-94. PubMed ID: 24206272 [TBL] [Abstract][Full Text] [Related]
14. Assessing Allosteric Modulation of CB Scott CE; Kendall DA Methods Enzymol; 2017; 593():317-342. PubMed ID: 28750809 [TBL] [Abstract][Full Text] [Related]
15. Allosteric modulators targeting cannabinoid cb1 and cb2 receptors: implications for drug discovery. Gado F; Meini S; Bertini S; Digiacomo M; Macchia M; Manera C Future Med Chem; 2019 Aug; 11(15):2019-2037. PubMed ID: 31517528 [TBL] [Abstract][Full Text] [Related]
17. Diarylureas as allosteric modulators of the cannabinoid CB1 receptor: structure-activity relationship studies on 1-(4-chlorophenyl)-3-{3-[6-(pyrrolidin-1-yl)pyridin-2-yl]phenyl}urea (PSNCBAM-1). German N; Decker AM; Gilmour BP; Gay EA; Wiley JL; Thomas BF; Zhang Y J Med Chem; 2014 Sep; 57(18):7758-69. PubMed ID: 25162172 [TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationship study of indole-2-carboxamides identifies a potent allosteric modulator for the cannabinoid receptor 1 (CB1). Mahmoud MM; Ali HI; Ahn KH; Damaraju A; Samala S; Pulipati VK; Kolluru S; Kendall DA; Lu D J Med Chem; 2013 Oct; 56(20):7965-75. PubMed ID: 24053617 [TBL] [Abstract][Full Text] [Related]
19. Mapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding Probe. Laprairie RB; Kulkarni AR; Kulkarni PM; Hurst DP; Lynch D; Reggio PH; Janero DR; Pertwee RG; Stevenson LA; Kelly ME; Denovan-Wright EM; Thakur GA ACS Chem Neurosci; 2016 Jun; 7(6):776-98. PubMed ID: 27046127 [TBL] [Abstract][Full Text] [Related]
20. Allosteric modulation of a cannabinoid G protein-coupled receptor: binding site elucidation and relationship to G protein signaling. Shore DM; Baillie GL; Hurst DH; Navas F; Seltzman HH; Marcu JP; Abood ME; Ross RA; Reggio PH J Biol Chem; 2014 Feb; 289(9):5828-45. PubMed ID: 24366865 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]